STAT3 and lung adenocarcinoma: Based on the knowledge mentioned above and our new findings that metformin repressed the IL-6-activated STAT3 phosphorylation, we suggest that metformin inhibits IL-6-induced EMT and metastasis of lung adenocarcinoma cells via blockade of STAT3 phosphorylation.